Many Big Reforms In Three Years, More To Follow, Says Government
New Delhi: The government has initiated a lot of big ticket and systemic reforms in the last three years and will continue efforts to consolidate the gains as also take up more economic measures in the remaining two years, Union Minister Nirmala Sitharaman has said. The commerce and industry minister said the government pursued reforms in a host of sectors, including banking, real estate, taxation, aviation and commercial dispute resolution.
"In the three years, both big ticket and systemic reforms have been taken in a calibrated fashion," she told news agency Press Trust of India on the occasion of the NDA government completing three years in power.
The reforms have been undertaken at every level of governance, she said, adding the government has the mandate for five years and there are two more years to go during which consolidation would happen.
"We need to consolidate" on reforms and take up new things in the months to come with a view to boost economic development, Ms Sitharaman said.
She further said that because of the various initiatives taken by the government, the confidence of overseas and domestic investors have improved.
Foreign direct investment (FDI) into India increased by 9 per cent to a record level of $43.48 billion in 2016-17. After coming to power in May 2014, the government started a range of reforms in various sectors like taxation, FDI policy, power, aviation and infrastructure.
During the last three years, the government eased foreign investment norms in as many as 21 sectors covering 87 areas. FDI equity inflows in the last three financial years rose by about 40 per cent to $114.41 billion as against $81.84 billion during the previous three fiscal years (2011-14).Â
-
Getting To Work Costs Women More | The Reason Why
It is not just about women paying more than men. It is about women paying much more in cities than in villages.
-
AI Bias In Investing Cannot Be Eliminated, But It Can Be Governed
Framing is a particularly important example as identical financial information presented in terms of gains rather than losses can lead an LLM to reach a different assessment.
-
Joining The Dots | Dark Skies, Steady Diya: Why Hope Holds This Diwali
With war, a weak rupee and foreign outflows weighing on sentiment, policymakers at the NDTV World Summit and market veterans at NDTV Profit Ignite: Diwali Edition offered the same advice: stay invested and filter out the noise.
-
The Curious Case of Equitas Small Finance Bank And A CEO Who Quit For Stock
PN Vasudevan believes persistent investor concerns over a perceived conflict of interest had become a governance overhang on Equitas Small Finance Bank's stock, even as the lender improved profitability and asset quality.
-
Talking Points This Week: AI Cash Burn, A Tiger Comeback And An India That Still Finds Its Own Path
India is not immune to higher oil or tighter global liquidity, yet its earnings base is broader, its domestic policy levers are still available.
-
Foreign Investors Own Half Of HDFC Bank and ICICI Bank. An LTCG Cut Could Matter Most Here
Foreign portfolio investors have US$115 billion parked in HDFC Bank, ICICI Bank. If the government cuts long-term capital gains tax, Jefferies says returning foreign money could land here first.
-
'Never Seen This Level Of Negativity': Sandeep Tandon Says The Next Rally May Be Closer Than You Think
Veteran investor Sandeep Tandon says foreign selling is easing, large-caps are due a comeback and mid-caps are crowded, while he turns positive on gold, power and pharma this Diwali.
-
Indians Stay With Family, Not In Hotels | The Reason Why
India still lacks enough clean, reliable and affordable hotels for budget-conscious travellers.
-
The Economic Imperative: Analysing The Material Driving Force Behind India-Canada Strategic Reset
This economic complementarity is further reinforced by deep institutional investment ties and talent mobility, which form the bedrock of the bilateral framework.
-
Medicine Pricing: Where Must Profit Stop?
India must confront excessive margins, hidden incentives and regulatory gaps that threaten the integrity of medicine.